Abou-Shady M, Baer H U, Friess H, Berberat P, Zimmermann A, Graber H, Gold L I, Korc M, Büchler M W
Department of Visceral and Transplantation Surgery, University of Bern, Switzerland.
Am J Surg. 1999 Mar;177(3):209-15. doi: 10.1016/s0002-9610(99)00012-4.
Transforming growth factor betas (TGF-betas) are multifunctional polypeptides that have been suggested to influence tumor growth. They mediate their functions via specific cell surface receptors (type I ALK5 and type II TGF-beta receptors). The aim of this study was to analyze the roles of the three TGF-betas and their signaling receptors in human hepatocellular carcinoma (HCC).
HCC tissue samples were obtained from 18 patients undergoing partial liver resection. Normal liver tissues from 7 females and 3 males served as controls. The tissues for histological analysis were fixed in Bouin's solution and paraffin embedded. For RNA analysis, freshly obtained tissue samples were snap frozen in liquid nitrogen and stored at -80 degrees C until used. Northern blot analysis was used in normal liver and HCC to examine the expression of TGF-beta1, -beta2, -beta3 and their receptors: type I ALK5 (TbetaR-I ALK5), type II (TbetaR-II), and type III (TbetaR-III). Immunohistochemistry was performed to localize the corresponding proteins.
All three TGF-betas demonstrated a marked mRNA overexpression in HCC in comparison with normal controls, whereas the levels of all three TGF-beta receptors showed no significant changes. Intense TGF-beta1, TGF-beta2, and TGF-beta3 immunostaining was found in hepatocellular carcinoma cells and in the perineoplastic stroma with immunohistochemistry, whereas no or mild immunostaining was present in the normal liver. For TbetaR-I ALK5 and TbetaR-II, the immunostaining in both HCC and normal liver was mild to moderate, with a slightly higher intensity in the normal tissues.
The upregulation of TGF-betas in HCC suggests an important role for these isoforms in hepatic carcinogenesis and tumor progression. Moreover, the localization of the immunoreactivity in both malignant hepatocytes and stromal cells suggests that TGF-betas act via autocrine and paracrine pathways in this neoplasm.
转化生长因子β(TGF-β)是多功能多肽,已被认为会影响肿瘤生长。它们通过特定的细胞表面受体(I型ALK5和II型TGF-β受体)介导其功能。本研究的目的是分析三种TGF-β及其信号受体在人类肝细胞癌(HCC)中的作用。
从18例接受部分肝切除术的患者中获取HCC组织样本。7名女性和3名男性的正常肝组织作为对照。用于组织学分析的组织用Bouin溶液固定并石蜡包埋。对于RNA分析,将新鲜获得的组织样本在液氮中速冻并储存在-80℃直至使用。采用Northern印迹分析检测正常肝脏和HCC中TGF-β1、-β2、-β3及其受体:I型ALK5(TβR - I ALK5)、II型(TβR - II)和III型(TβR - III)的表达。进行免疫组织化学以定位相应的蛋白质。
与正常对照相比,所有三种TGF-β在HCC中均表现出明显的mRNA过表达,而所有三种TGF-β受体的水平均无显著变化。免疫组织化学显示,在肝癌细胞和肿瘤周围基质中发现强烈的TGF-β1、TGF-β2和TGF-β3免疫染色,而正常肝脏中无或仅有轻度免疫染色。对于TβR - I ALK5和TβR - II,HCC和正常肝脏中的免疫染色均为轻度至中度,正常组织中的强度略高。
HCC中TGF-β的上调表明这些异构体在肝癌发生和肿瘤进展中起重要作用。此外,免疫反应性在恶性肝细胞和基质细胞中的定位表明TGF-β在该肿瘤中通过自分泌和旁分泌途径发挥作用。